Clinical Site

Columbus, Ohio 43213

2 studies enrolling now · 4 studies all time

What they study most

C3 Glomerulopathy (C3G), Generalized Anxiety Disorder, Hidradenitis Suppurativa

Studies at this site

• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed